Introduction
The border between extrapleural solitary fibrous tumour and hemangiopericytoma has recently become increasingly blurred. Perivascular stem cells with the capacity for lipocytic and fibroblastic/myofibroblastic differentiation are involved in the pathogenesis of various mesenchymal tumours 1 . This report discusses a case of a lipomatous hemangiopericytoma-solitary fibrous tumour (HPC-SFT) of low malignant potential.
Case report
We report a case of a tumour in the deep soft tissues of the thigh of a 73-year-old man. The tumour had developed in the last 6 months before its surgical resection, and its maximum diameter was 6 cm.
Morphologically, it was a well-demarcated neoplasm consisting of a varying combination of patternless cellular areas, prominent hemangiopericytoma-like vessels, variably collagenized extracellular matrix and lipomatous areas of mature lipocytes (Figures 1-4 ). There was a focal presence of variably ectatic or compressed, thin-walled branching vessels often having a staghorn configuration ( Figure 3 ). Tumour cells are spindle shaped to round, generally of uniform size with small amounts of pale or eosinophilic cytoplasm with indistinct margins and often bland nuclei; however, some giant tumour cells with atypical nuclei were occasionally noticed ( 4 In most studies, hemangiopericytoma and cellular solitary fibrous tumours are usually considered as synonyms because considerable immunohistochemical and morphological features overlap between SFT and HPC. The World Health Organization recognizes that SFT and HPC are two similar entities, if not identical 5 .
Although HPC and SFT are not the same entity, features of both diseases can be found in the same patient. This is called HPC-SFT, the diagnosis of the case that we report. Cases of HPC-SFT are quite rare; in fact, a little amount of cases (around 60) have been reported.
SFTs are commonly associated with a benign clinical course; however, a few cases that show benign histologic features can behave aggressively. Malignant features for SFT are hypercellularity, nuclear atypia, mitoses >4/10 HPFs, necrosis, haemor- rhage, pleomorphism and recurrence on presentation. Tumour giant cells can be found in this entity, though its presence is not considered a specific malignant feature 6 .
With regard to differential diagnosis, there are some closely interrelated entities that complicate the diagnosis of HPC-SFT. For example, HPC-SFT that contains fat may be misdiagnosed for well-differentiated or dedifferentiated liposarcoma. We can differentiate between HPC-SFT and myxoid liposarcomas by the presence of interstitial hyalinization, coarse-walled vessels and the absence of immature lipoblasts. Another histological finding that helps differentiation between these two entities is that in myxoid liposarcomas, vessels are not surrounded by pericytes as opposed to SFT 7 . Another myxoid tumour that can cause confusion with SFT is myxofibrosarcoma. The main difference is that SFT contains lipoblast-like cells that have fat vacuoles or mature adipocytes, in contrast to myxofibrosarcoma that does not form fat 7 .
Conclusion
The diagnosis of HPC-SFT can be confused as well with angiofibroma, spindle-cell/pleomorphic lipoma and mammary-type myofibroblastoma because they are also collagenous spindle-cell tumours containing adipocytes and sometimes are reactive to CD34. However, the last three entities have a specific pattern, whereas HPC-SFTs demonstrate a distinctive hemangiopericytomatous pattern.
